<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34930370</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production.</ArticleTitle><Pagination><StartPage>255</StartPage><MedlinePgn>255</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">255</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-021-01725-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Enterovirus 71 (EV71) usually infects infants causing hand-foot-mouth disease (HFMD), even fatal neurological disease like aseptic meningitis. Effective drug for preventing and treating EV71 infection is unavailable currently. EV71 3C mediated the cleavage of many proteins and played an important role in viral inhibiting host innate immunity. Promyelocytic leukemia (PML) protein, the primary organizer of PML nuclear bodies (PML-NBs), can be induced by interferon and is involved in antiviral activity. PML inhibits EV71 replication, and EV71 infection reduces PML expression, but the molecular mechanism is unclear.</AbstractText><AbstractText Label="METHODS">The cleavage of PMLIII and IV was confirmed by co-transfection of EV71 3C protease and PML. The detailed cleavage sites were evaluated further by constructing the Q to A mutant of PML. PML knockout cells were infected with EV71 to identify the effect of cleavage on EV71 replication. Immunofluorescence analysis to examine the interference of EV71 3C on the formation of PML-NBs.</AbstractText><AbstractText Label="RESULTS">EV71 3C directly cleaved PMLIII and IV. Furthermore, 3C cleaved PMLIV at the sites of Q430-A431 and Q444-S445 through its protease activity. Overexpression of PMLIV Q430A/Q444A variant exhibited stronger antiviral potential than the wild type. PMLIV Q430A/Q444A formed normal nuclear bodies that were not affected by 3C, suggesting that 3C may impair PML-NBs production via PMLIV cleavage and counter its antiviral activities. PML, especially PMLIV, which sequesters viral proteins in PML-NBs and inhibits viral production, is a novel target of EV71 3C cleavage.</AbstractText><AbstractText Label="CONCLUSIONS">EV71 3C cleaves PMLIV at Q430-A431 and Q444-S445. Cleavage reduces the antiviral function of PML and decomposes the formation of PML-NBs, which is conducive to virus replication.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Zhuoran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Ya'ni</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenqian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China. juantan@nankai.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Wentao</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-0449-694X</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China. wentaoqiao@nankai.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071156">Promyelocytic Leukemia Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071156" MajorTopicYN="N">Promyelocytic Leukemia Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">Cleavage</Keyword><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">PML nuclear bodies (PML-NBs)</Keyword><Keyword MajorTopicYN="N">Promyelocytic leukemia (PML)</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34930370</ArticleId><ArticleId IdType="pmc">PMC8686290</ArticleId><ArticleId IdType="doi">10.1186/s12985-021-01725-7</ArticleId><ArticleId IdType="pii">10.1186/s12985-021-01725-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Crom SC, Rossen JW, van Furth AM, Obihara CC. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 2016;175:1023&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930465</ArticleId><ArticleId IdType="pubmed">27156106</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick JL, Schmidt NJ, Mirkovic RR, Chumakov MP, Lavrova IK, Voroshilova MK. Identification of Bulgarian strain 258 of enterovirus 71. Intervirology. 1980;12:297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">6244233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>World-Health-Organization . Hand, foot and mouth disease situation update 2018. World-Health-Organization; 2018.</Citation></Reference><Reference><Citation>Teoh HL, Mohammad SS, Britton PN, Kandula T, Lorentzos MS, Booy R, Jones CA, Rawlinson W, Ramachandran V, Rodriguez ML, et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol. 2016;73:300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Chen LL, Huang PN, Shih SR. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 2010;12:505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol. 2011;37:313&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wu Z, Jin Q. COPI is required for enterovirus 71 replication. PLoS ONE. 2012;7:e38035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360637</ArticleId><ArticleId IdType="pubmed">22662263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu XF, Zhang W. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS ONE. 2012;7:e32405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Y. Recent progress on functional genomics research of enterovirus 71. Virol Sin. 2019;34:9&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Qi Z, Wang J. The function and mechanism of enterovirus 71 (EV71) 3C protease. Curr Microbiol. 2020;77:1968&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pubmed">32556480</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, Lee JC, Hwang MJ, Li ML, Chen GW, Ho MS. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci. 2004;11:239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5:e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yao Y, Chen Y, Xu X, Lin Y, Yang Z, Qiao W, Tan J. Enterovirus 71 3C promotes apoptosis through cleavage of PinX1, a telomere binding protein. J Virol. 2017;91:e02016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215332</ArticleId><ArticleId IdType="pubmed">27847364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wo X, Yuan Y, Xu Y, Chen Y, Wang Y, Zhao S, Lin L, Zhong X, Wang Y, Zhong Z, Zhao W. TAR DNA-binding protein 43 is cleaved by the protease 3C of enterovirus A71. Virol Sin. 2021;36:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973337</ArticleId><ArticleId IdType="pubmed">32696397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol. 2013;87:1690&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, He X, Zheng Z, Zhang Z, Wei C, Guan K, Hou L, Zhang B, Zhu L, Cao Y, et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J Virol. 2014;88:11356&#x2013;11368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Lei X, Xiao X, Yang C, Lu W, Huang Z, Leng Q, Jin Q, He B, Meng G, Wang J. Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep. 2015;12:42&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 2007;8:1006&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">17928811</ArticleId></ArticleIdList></Reference><Reference><Citation>de Th&#xe9; H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR&#x3b1; fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991;66:675&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">1652369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR&#x3b1; with a novel putative transcription factor, PML. Cell. 1991;66:663&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">1652368</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F, Grignani F, Pelicci PG. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene. 1991;6:1285&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pubmed">1650447</ArticleId></ArticleIdList></Reference><Reference><Citation>El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK. Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog. 2014;10:e1003975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937294</ArticleId><ArticleId IdType="pubmed">24586174</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene. 2001;20:7223&#x2013;7233.</Citation><ArticleIdList><ArticleId IdType="pubmed">11704850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Feng C, Tian X, Zheng N, Wu Z. Promyelocytic leukemia restricts enterovirus 71 replication by inhibiting autophagy. Front Immunol. 2018;9:1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996053</ArticleId><ArticleId IdType="pubmed">29922292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D, Chen S, Cheng A, Wang M. Roles of the picornaviral 3C proteinase in the viral life cycle and host cells. Viruses. 2016;8:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810272</ArticleId><ArticleId IdType="pubmed">26999188</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer M, Stamminger T. Emerging role of PML nuclear bodies in innate immune signaling. J Virol. 2016;90:5850&#x2013;5854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4907236</ArticleId><ArticleId IdType="pubmed">27053550</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Lin JY, Chen BS, Weng KF, Shih SR, Calderon JD, Tolbert BS, Brewer G. EV71 3C protease induces apoptosis by cleavage of hnRNP A1 to promote apaf-1 translation. PLoS ONE. 2019;14:e0221048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733512</ArticleId><ArticleId IdType="pubmed">31498791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Han N, Xiao X, Jin Q, He B, Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J Virol. 2014;88:9830&#x2013;9841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Livingston MJ, Su Y, Dong Z. Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways. Autophagy. 2015;11:607&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502771</ArticleId><ArticleId IdType="pubmed">25906314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I. Proteasomal and autophagic degradation systems. Annu Rev Biochem. 2017;86:193&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">28460188</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshavsky A. The ubiquitin system, autophagy, and regulated protein degradation. Annu Rev Biochem. 2017;86:123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">28654326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelbi-Alix MK, de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene. 1999;18:935&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">10023669</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol. 2006;80:8582&#x2013;8592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1563870</ArticleId><ArticleId IdType="pubmed">16912307</ArticleId></ArticleIdList></Reference><Reference><Citation>El McHichi B, Regad T, Maroui MA, Rodriguez MS, Aminev A, Gerbaud S, Escriou N, Dianoux L, Chelbi-Alix MK. SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol. 2010;84:11634&#x2013;11645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2977872</ArticleId><ArticleId IdType="pubmed">20826694</ArticleId></ArticleIdList></Reference><Reference><Citation>Flather D, Semler BL. Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol. 2015;6:594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4471892</ArticleId><ArticleId IdType="pubmed">26150805</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoffroy MC, Chelbi-Alix MK. Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res. 2011;31:145&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">21198351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, Wang J, Wang M, Jin Q. Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408:449&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Differential roles of PML isoforms. Front Oncol. 2013;3:125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3660695</ArticleId><ArticleId IdType="pubmed">23734343</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>